Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Graphic novel tackles disinformation around COVID-19 Vaccine and critical 5G infrastructure

Stockwood Strategy

Sophisticated social media campaigns sponsored by bad state actors are responsible for creating and spreading disinformation around the critical Covid-19 Vaccine and emerging infrastructure such as 5G technology for communications. Erly Stage Studios has today published Bug Bytes, the digital graphic novel, which sheds a light on the disruptive forces at work. This book is the second installment of the graphic novels that are a part of the Resilience Series commissioned by the US Cyber Infrastructure and Security Agency (CISA). Bug Bytes will inform and educate people on the dangers and risks associated with dis- and mis- information through fictional stories inspired by real-world events. In Bug Bytes, readers will meet the protagonist Ava Williams, a journalist and academic, patriot and member of Symous - a group fighting disinformation and foreign interference in elections as polling day approaches. Ava’s life gets tangled up in a web of lies as her father, a 5G technician gets hurt and she works to understand what a seemingly innocent poll online related to 5G technology has to do with the 5G Vaccine? Ava is surprised by the reaction of the anti-vaccination community at what is proven to be engineered data and has the unenviable task of making the case to the public at large for how they can be weary on data online with unproven provenance. Farid Haque, founder and CEO of Erly Stage Studios commented: “We’re delighted to have been commissioned by CISA to create a practical and engaging communication tool that highlights the existential threat of disinformation in the context of bad state actors. While the story is fictional many of the approaches shown are very much grounded in the reality of the technology we live with and are exposed to almost daily.” Bug Bytes provides a unique education for the reader about the world of social media and how digital resources can be hijacked to serve a more nefarious agenda. The ability for foreign bad state actors to weld this kind of influence on another nation is unprecedented as is their ability to twist and manipulate a narrative to use domestic groups to do their bidding. The work helps the reader understand the need to exercise care when it comes to consuming news and information via social media platforms and online sources of information. In the story, Ava Williams and a team of patriots are racing against the clock to shine a spotlight on the source of disinformation engineered to hurt critical communication infrastructure and damage the Vaccine roll-out efforts. Ava’s investigative journalism leads her through the metaverse to find allies and discovers through hard graft that foreign actors are tinkering with public data to maliciously mislead and influence perceptions of 5G as a communications technology and its fabricated link to vaccine effectiveness. “Bug Bytes is the culmination of the wealth of experience that Clint Watts brings in cyber warfare and disinformation and our studio’s creative direction and storytelling style. We spent months researching the real life incidents and then wrapped them into a fictional story” added Farid Haque. The graphic novel is being made available by CISA to the general public online as a free resource as the Covid19 vaccine roll out continues to have an impact across the United States and the world at large. The work is available for free for the public and media to read at the following URL: https://www.cisa.gov/cfi-resilience-series-graphic-novels. A first title in the series was released a few months earlier last year ahead of the US elections titled Real Fakes. Watch this space and log back into https://publishing.erlystagestudios.com/ to learn more. Contributing artists to Bug Bytes include: Jose Niño Galenzoga, Patricia Beja, Mona Shan and Joel Santiago. Lettering and layouts by Komal N. and Haroon M. Story by Clint Watts and Farid Haque, supported by the script writing team which includes Michael Gianfrancesco and Kabir Sabharwal. Edited by Tolly M. and Laila Khan. Special thanks to Randall Heather and Max Brooks. Erly Stage Studios is an indie publisher, headquartered out of London, United Kingdom, capturing iconic stories in serious graphic novels. We are an expert team of educators, storytellers, and artists working to create awareness about important topics using the graphic novel medium. The team loves shining a spotlight on stories that are yet to see the light of graphic novels. As an expert team of teachers, researchers and designers the team works with innovative organisations and policymakers around the world to deliver soft power through engaging and creative projects. Contact Details Erly Stage Studios Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://publishing.erlystagestudios.com/

May 06, 2021 05:00 AM Eastern Daylight Time

Image

Shreesha Ramdas to join CIPIO’s Advisory Board to hyper accelerate growth

CIPIO.ai

CIPIO, a B2C Subscription Success company, today announced that Shreesha Ramdas has joined its board of advisors. Ramdas currently serves as SVP and GM for Medallia-owned Strikedeck – a powerful customer success automation solution. Prior to Medallia, Ramdas co-founded Leadformix, a marketing automation platform acquired by CallidusCloud in 2012. A seasoned entrepreneurial executive with a proven track record of launching and rapidly scaling automation solutions for customer success and marketing, Ramdas is constantly on the lookout for the “next big thing” in the customer engagement world – an attitude that led him to join CIPIO’s advisory board. Customer churn is a rampant reality in the B2C Subscription industry, given how easy it is for customers to downgrade, switch, or cancel service providers in a matter of just a few clicks. Industry study suggests that 96% of B2C Subscription businesses believe their customers churn for reasons that could have been prevented, managed, or fixed. Post Covid, Net Revenue Retention (NRR), and Customer Retention have become strategic priorities for B2C Subscription companies and will continue to become table stakes over time. According to Bain and Company, increasing customer retention rates by just 5% increases 25% profits for B2C Subscription companies. “In a world where the bar for customer engagement keeps going higher, I love how CIPIO is redefining customer retention - making it actionable, easy and impactful for B2C Subscription companies through its Data Apps,” said Ramdas. “The SaaS landscape continues to explode with solutions, yet there are literally very few solutions solving NRR and Customer Retention for the B2C Subscription companies. With its code-free Enterprise AI and Domain-Infused Data Apps Platform™, CIPIO offers the precise action to drive measurable results for B2C Subscription companies.” With the B2C Subscription Economy expected to be valued at a whopping $478 billion by 2025, it is surprising that the industry’s churn rate is two times that of the B2B SaaS Economy. CIPIO’s Domain-Infused Data Apps Platform™ aims to tip this balance back and level the playing field. “I’m ecstatic to have Shreesha onboard as we move full-speed into our next phase of growth and innovation. The hybrid economy is here, and you can no longer hope to just focus on acquisition as it costs five times as much to attract a new customer than to keep an existing one,” said Growson Edwards, Co-Founder, and CEO of CIPIO. “Our mission is to enable B2C Subscription companies to proactively prevent churn and achieve higher Net Retention Rate for consistent growth. Shreesha’s obsession and tremendous experience in launching customer success solutions and product experience will accelerate our product innovation yielding higher returns for our customers.” About CIPIO CIPIO is pioneering the Industry's first domain-infused Data Apps Platform™ that humanizes and automates predictions and recommendations to increase Subscriber engagement, retention, and growth for B2C Subscription Companies. CIPIO's early adopters include Crunch Fitness, Industry's Gym, Xponential Fitness, Motor City Church, Pure Barre, Club Pilates, AKT, YogaSix, NCFit, Cyclebar, RowHouse, Stretch Lab, and Stride who have witnessed a significant return on investment in a short time. Contact Details CIPIO Chris Foudy +1 831-238-1905 chris@cipio.ai Company Website https://cipio.ai/

May 04, 2021 02:20 PM Eastern Daylight Time

Cloudrise Honored as Gold Stevie® Award Winner

Cloudrise

Cloudrise was named the winner of a Gold Stevie® Award in the Tech Startup of the Year – Services category in The 19 th Annual American Business Awards®. More than 3,800 nominations – a record number - from organizations of all sizes and in virtually every industry were submitted this year for consideration in a wide range of categories. As the Gold medal recipient in the category of “ Tech Startup of the Year – Services ”, Cloudrise was heralded by the judges: “Cloudrise’s data-centric approach to cybersecurity, and use of automation, are very much needed services for organizations to enable the digital transformation journey.” Cloudrise was founded in October 2019, and in 2020 they conquered the seemingly impossible, launching a new company amidst a global pandemic and economic downturn. Despite those challenges, Cloudrise had a successful year one in business, exceeding 2020 revenue targets, securing capital investments through investors, and delivering Managed Services and Security Process Automation to over 50 customers. Cloudrise’s CEO, Rob Eggebrecht, shared his thoughts about what makes Cloudrise different: “Cloudrise’s Security Process Automation services are a key differentiator in the marketplace. Organizations are dependent on data stored within a myriad of systems, requiring integration and automation to enable them to work at the speed of business. Cloudrise automates operational processes across data protection and privacy solutions, business applications, and visualization tools, to optimize manual processes, enhance reporting, and provide faster incident response. Starting with an assessment, we identify use cases, develop playbooks, and ultimately build, deploy, and manage the automation.” About the American Business Awards The American Business Awards are the U.S.A.’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations – public and private, for-profit and non-profit, large and small. Nicknamed the Stevies for the Greek word meaning “crowned,” the awards will be virtually presented to winners during a live event on Wednesday, June 30. Tickets for the virtual event are now on sale. More than 250 professionals worldwide participated in the judging process to select this year’s Stevie Award winners. “The American economy continues to show its resilience, and as we’re poised on the beginning of what should be a phenomenal period of growth, we celebrate the remarkable achievements of a wide range of organizations and people over the past 18 months,” said Stevie Awards president Maggie Gallagher. “This year’s Stevie-winning nominations in The American Business Awards are testament to the ingenuity, the commitment, the passion, the adaptability, and the creativity of the American people.” Details about The American Business Awards and the list of 2021 Stevie winners are available at www.StevieAwards.com/ABA. About the Stevie Awards Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com. Sponsors of The 2021 American Business Awards include John Hancock Financial Services, Melissa Sones Consulting, and SoftPro. About Cloudrise Cloudrise was founded by business and security entrepreneurs with experience in global markets, successful start-ups, and Fortune 500 companies. Combining decades of data protection expertise with automation, Cloudrise focuses on securing data wherever it resides. They assist organizations by assessing, enabling, automating, and managing their data protection and privacy programs. At Cloudrise, they are redefining data protection. Cloudrise can be found at www.cloudrise.com or on LinkedIn. Contact Details Jodi Lewis +1 800-917-7619 sales@cloudrise.com Company Website https://cloudrise.com/

May 04, 2021 11:11 AM Central Daylight Time

How To Reduce Social Security Taxes In Retirement by Jennifer Lang Financial Services

Jennifer Lang Financial Services, LLC

Contact Details Jennifer Lang Financial Services, LLC. Jennifer Lang +1 877-487-8926 mail@jenniferlangfinancialservices.com Company Website https://www.jenniferlangfinancialservices.com

May 04, 2021 10:05 AM Eastern Daylight Time

Video

CereMetrix Corp. Introduces Enhancements to its Advanced Medical Imaging and Analytics Platform

CereHealth

CereMetrix Corp., a wholly owned subsidiary of data analytics technology company CereHealth Corp., has released an enhanced version of its imaging platform, CereMetrixAi™. Using its FDA-cleared QSPECT ® analysis as a template, the platform can now incorporate additional imaging, such as MRI, PET and CT, and non-imaging analytical assessments through an expanding catalog of both in-house and third-party medical image algorithms. Its improved integration capabilities for data collection and reporting opens the door for broader use of non-imaging assessments like neuropsychological evaluations and cognitive screens and expands the platform’s clinical and research applications. CereMetrixAi™ is a browser-based, cloud-enabled, HIPAA-compliant imaging platform that features FDA-cleared QSPECT® analysis. The platform offers accessible, automated, and objective imaging to radiologists and treating providers to detect, quantify and analyze in significantly less time than other reading tools, and at significantly less expense than traditional workstation-based software solutions. Now with its open platform architecture, various sources of imaging and non-imaging data can be analyzed in a templated, customizable report that is available to clinicians and their patients anytime, anywhere through a browser. The new release offers efficiency and user experience enhancements to radiologists through inherent support for overreads, customizable templated language fields and a new interface for annotations and image capture. It also allows other medical imaging modalities such as MRI, PET and CT to take advantage of the three-dimensional visualization capabilities that were previously offered solely with SPECT brain studies. Third party imaging developers may now deliver their products to the market via CereMetrixAi’s browser-based platform, expanding the visualization options available and providing doctors a more complete path toward accurate diagnoses. “Our vision of bringing data driven medical imaging and analytics to healthcare professionals worldwide takes a giant leap forward with the introduction of CereMetrix 2.0,” said Shane Quint, Chief Technology Officer of CereHealth Corp. “By integrating all sources and types of patient data in a user-friendly platform we are enabling a more complete picture of an individual’s health for more effective diagnosis and treatment. It is the definition of Precision Medicine, and we are proud to be a leader in software solutions that make sense for patients, providers and researchers at all levels.” Personalized Medicine, matching a specific patient to a similar patient group, will be realized when the entirety of factors affecting a person’s health are considered. Then disease prevention and treatment can be tailored around their unique characteristics. By seamlessly integrating digital health data of all types, CereHealth’s technologies enable medical professionals (and researchers) to advise with precision and accuracy the best diagnostic outcome leading to the right treatment for the right patient at the right time in their lives. About CereHealth CereHealth is a data analytics technology company that provides Medical Analytics as a Service (MAaaS), enabling doctors, research scientists and others serving the healthcare community to quickly make more-informed decisions regarding patient-specific treatments for a higher likelihood of success to improve outcomes and patients’ quality of life. CereHealth is a leader in multivariable analysis of quantitative biomarkers for central nervous system (CNS) disorders with 2 patents on neuroimaging database systems and methods (and 1 patent pending), and a proprietary growing database of more than one million structured patient datapoints that include neuro imaging, cognitive assessments, detailed clinical history, and blood biomarkers. Though our structured database focuses on CNS disorders, our software is not limited to a disease, brain region, or any biomarker. To learn more about CereHealth’s MAaaS solutions, including scheduling a live demonstration visit us at ceremetrix.io. Contact Details CereHealth Corp. Shane Quint, Chief Technology Officer +1 303-282-4702 squint@cerescan.com Company Website https://ceremetrix.io/

May 04, 2021 07:00 AM Mountain Daylight Time

ZOE Announces $53M Total Raise From Investors Including Fund Backed By Top Scientists, and Two-Time Super Bowl Champion Eli Manning

ZOE

Healthcare science company ZOE announced today it has raised $53M in total funding to transform how individuals eat with a first-of-its-kind at-home test kit and personalized advice program. ZOE decodes each customer’s unique biological responses to food, and guides them on how to eat to maximize long-term health. The program uses machine learning combined with the world’s largest nutrition research studies. These funds will allow ZOE to meet the dramatic rise in customer demand since it launched a few months ago, and serve millions of people in search of a sustainable and science-backed approach to healthy eating. Addressing high rates of obesity, metabolic disease, and nutritional confusion, ZOE launched its first product in September 2020 after three years in stealth carrying out the world’s largest in-depth nutrition and microbiome study with scientists from Harvard, King’s College London, Mass General Hospital and Stanford. The test kit analyzes users’ gut health, as well as blood fat and blood sugar responses to food and uses these insights to provide daily, personalized nutrition guidance. Demand is high and ZOE is currently in waitlist-mode. Interim clinical trial results reveal participants experienced more energy (90%), felt less hunger (80%) and lost an average of 11 pounds after three months of following their personalized plan. Today’s B round of over $20M brings cash on the balance sheet to $40M. This round of financing is led by Ahren Innovation Capital (“Ahren”), whose Science Partners include two Nobel laureates. Sir Gregory Winter CBE FRS FMedSci and Nobel Prize winner for Chemistry said: “We were interested both by the approach taken by ZOE, in which they are applying machine learning to large scale population data, and by their published results, in which they are mapping out associations between diet, health and the gut microbiome.” Additional participants in this financing include two-time Super Bowl Champion and MVP Eli Manning, two-time Super Bowl Champion and award-winning sportscaster Ositadimma "Osi" Umenyiora, Accomplice (the fund behind AngelList, DraftKings, PillPack, and WHOOP), THVC and Daphni. Umenyiora said, “I'm really excited to invest in ZOE. As an athlete, I know how much eating the right food changes how I feel and how I perform.” The funds from the investment will be used to speed up the rollout of the ZOE program. Currently, the program is only available in the US, but a launch is intended in the UK in 2021 and further geographies in 2022. ZOE is continuing to hire rapidly, including in engineering and science, where its expertise spans from microbiome and nutrition to metabolic research and machine learning. Commenting on the investment, George Hadjigeorgiou, co-founder and President of ZOE, said: "We started ZOE because we believe that everyone has a right to understand how their body responds to food so they can make their own decisions and be in control of their health. We are thrilled to be partnering with a distinguished group of new and existing investors to continue on our mission to help people live healthier and happier lives.” “After 4 years of research and results published in the world’s leading medical journals, we are delighted to accelerate the launch of the ZOE program because we believe people need our help,” said Jonathan Wolf, co-founder and CEO of ZOE. “Ahren Innovation Capital, Eli Manning and Osi Umenyiora’s backing of ZOE further validates the belief held by leaders across diverse industries that we can have a powerful impact on our health through in-depth, personalized insights into our biology.” Science Supported with Multiple Papers Published in Top Peer-Reviewed Journals Experiencing rapid revenue growth and forecasting double-digit millions of revenue in its first year of sales, ZOE uses a data-driven approach to tackling global health issues. The company combines artificial intelligence, digital technologies and collaboration with world-leading scientists. ZOE’s research has led to over a dozen peer reviewed studies in high impact journals over the last year, including multiple papers in leading science journals such as Nature Medicine. In March 2020 at the onset of the pandemic, the ZOE team felt compelled to help and responded by developing and launching an app in just four sleepless days and nights, built on their existing technologies. The free ZOE Covid Study app, which is a non-profit initiative, now has more than 4.5M users across the UK, US and Sweden, calculating levels of COVID in real-time and sharing anonymous data with researchers across the world. Scientists working with ZOE have published dozens of scientific papers as a result, from understanding COVID symptoms to data on vaccine effectiveness and COVID’s long-term effects. Long-term, ZOE intends to use the app to support wider public health initiatives. About ZOE ZOE is a healthcare science company helping people understand their body’s responses to food. By using machine learning combined with large scale human studies, ZOE is decoding the impact of nutrition on health. ZOE leads the PREDICT Studies and the ZOE COVID Study, which are the world’s largest community powered research programs of their kind in nutrition and COVID-19 respectively. Located in London and Boston, ZOE was founded by Professor Tim Spector of King’s College London, data science leader Jonathan Wolf and entrepreneur George Hadjigeorgiou. ZOE was named one of the Deloitte Fast 50 Rising Stars in 2019 for the company’s contribution to science enabled by technology and machine learning. For more information on ZOE’s mission and science, visit joinzoe.com. Recently Published Nutrition Studies Postprandial glycaemic dips predict appetite and energy intake in healthy individuals, Nature Metabolism,April 12, 2021 Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals, Nature Medicine, January 11, 2021 Human postprandial responses to food and potential for precision nutrition, Nature Medicine, June 11, 2020 About Ahren Innovation Capital Ahren Innovation Capital is an investment institution that supports transformational companies at the intersection of deep tech and deep science that will penetrate, or create, massive markets. Ahren is a unique partnership of investment talent and best-in-class commercial scientists whose technologies are today valued in excess of $100BN combined. Ahren believes in taking asymmetric, considered, risk that will deliver superior rewards – capturing a generational opportunity to provide smart capital to deep technology. With a philosophy espousing the importance of relationships and trust, Ahren provides both patient and active capital to exceptional founders and teams, empowering them to succeed. For more information on Ahren Innovation Capital, visit ahreninnovationcapital.com. Contact Details ZOE Fiana Tulip +1 817-691-3031 fiana@joinzoe.com Company Website https://www.joinzoe.com

May 04, 2021 07:53 AM Eastern Daylight Time

Image

WEED AND WHISKEY NEWS SIGNS ON AS PARTNER FOR WILLIE NELSON'S LUCK SUMMIT.

W And W Digital, LLC

Executive Producer Jerry Joyner at W And W Digital, LLC, discussed the announcement during a live broadcast from Dallas, Texas on Tuesday, April 27th, 4:20 pm 2021 from their headquarters in Deep Ellum. “The Luck Summit is just what the doctor ordered in many ways, exclaimed Joyner. I think most Texans believe that our lone star state will be the last to pass the legalization for the use of recreational cannabis, but with efforts like Willie Nelson and his team at the Luck Summit, paired with the High Holidays, I believe Texans will get the cannabis relief they need sooner than later. For me, I partake when I can, but there are hundreds of thousands of people that could be managing pain and health issues with cannabis on a daily basis if legalization legislation can be passed down in Austin. It’s a hell of a lot better than opioids.”, added Joyner. The multi-day virtual summit, seeks to destigmatize, educate, and promote cannabis culture in an informative and entertaining way. During the summit, Luck Presents and cannabis advocates will discuss the plant from a political, ethics, economic, wellness, community, industry and science point of view. Planting the Seed is the marque event of Luck’s “High Holidays”, a 9 day celebration of the cannabis plant and it’s many benefits which began on 4/20 and ends on Willie’s birthday, 4/29. Additionally, Luck Presents is petitioning the Biden Administration and Congress to make 4/20 to 4/29 the “High Holidays” in honor of the cannabis industry and to celebrate Willie’s birthday. “If you haven’t seen Willie Nelson’s letter to President Joe Biden petitioning for the High Holidays, you should and here it is”, added Joyner. The on-line petition can be found here. Weed And Whiskey News is a content distribution studio focusing on Cannabis, Whiskey, Music and the culture within. Their website, live streaming portal and social channels have developed series content including: Infused Kitchen, Miracles of Marijuana, Sips and Quips and The Green Room with Jimmy Vivino. The Green Room with Jimmy Vivino is a weekly Zoom-Cast talk show featuring host and guitar legend Jimmy Vivino and weekly special guests including celebrities, musicians, power house producers, iconic promoters, prolific writers and legendary comedians. Weed And Whiskey TV is an On-Demand TV Network, featuring original, highly-entertaining cannabis and spirit friendly programming. The vast majority of their original programming is only four minutes and 20 seconds in length and can be viewed on virtually any mobile device. Weed and Whiskey TV also streams curated music concerts, feature films, shows and Holiday specials. Twist one up, pour a whiskey...sit back, relax and enjoy Weed And Whiskey TV. It's TV with a Twist! W And W Digital, LLC is an entertainment and media holding concern headquartered in Dallas, Texas. W And W Digital owns and operates the streaming TV Network, Weed And Whiskey TV. In addition to licensed feature films and episodic series, W And W Digital created and produces the following episodic series. “DI High”, “Higher Than Space”, “History Written in Stoned,” “In Luck” (filmed at Willie Nelson’s Luck Reunion that coincides with SXSW), “Paper Bartender”, “Trailer Talks”, “Tequila Shots” and recently launched Weed And Whiskey News.com. Contact Details Weed And Whiskey News Jerry Joyner +1 214-762-7101 info@weedandwhiskeynews.com Company Website https://www.weedandwhiskeynews.com

April 28, 2021 08:45 AM Eastern Daylight Time

Image

Israeli AgTech genetics companies and academic researchers team up to apply the latest genomic selection algorithms to boost farming performance of freshwater shrimp in Asia

NRGene

Enzootic Genetics & Innovation, NRGene and Ben-Gurion University of the Negev will create a new technological consortium to apply the latest genomic selection technologies developed by NRGene for the enhancement of Enzootic’s freshwater shrimp breeding program and performance of its proprietary all-female populations. Enzootic Genetics & Innovation, an animal biotechnology and genetics company leading the all-female freshwater shrimp revolution, and NRGene (TASE: NRGN), an AI based genomic company operating in the agricultural industry, have signed a new technological collaboration agreement. Based on their successful cooperation from 2018 of sequencing and assembling the world’s first high-quality genome of freshwater shrimp M. rosenbergii, the two tech companies, together with researchers from the Life Sciences Department of Ben-Gurion University of the Negev, and the support of the Israel Innovation Authority, will harness NRGene’s novel quantitative genomics breeding tools and algorithms to Enzootic’s genetic selection program. The objective of this collaboration is the selection of superior breeding genetics that will eventually translate into an improvement in yield and revenues for farmers using Enzootic’s all-female freshwater shrimp. “Enzootic assimilates the latest genomic big data tools to accelerate our genetic selection program. Our previous successful collaboration with NRGene, and their pioneering genomic tools, paved the way for this milestone collaboration,” said Managing Director of Enzootic Genetics & Innovation Mr. Amit Hochman. “The continual performance improvement of our all-female population is attributed to data-driven parent populations selection, through Enzootic’s hatcheries in Asia and ultimately the yields of farmers that use this proprietary mono-sex farming strategy.” “Our new collaboration with Enzootic, alongside our past success, is part of NRGene’s strategy to support and enhance breeding of highly important aquaculture species, such as shrimp.” said Dr. Gil Ronen, NRGene’s CEO. “We continuously develop powerful big data analysis tools that navigate genetic selection programs like the one implemented in freshwater shrimp by Enzootic.” “This collaboration, together with academic researchers from Ben-Gurion University of the Negev, creates a unique opportunity to align population quantitative genomic data, with our basic science transcriptomic and metabolic libraries, investigated and studied by our group” said crustacean endocrinologist Prof. Amir Sagi of Ben-Gurion University of the Negev. “This alignment may shed new light on the understanding and regulation of key physiological processes in M. rosenbergii ”. About Enzootic Genetics & Innovation Enzootic Genetics & Innovation is the genetic production arm and R&D center of Enzootic, a Singaporean animal genetic and biotechnology company vertically positioned to support the breeding and farming of all-female freshwater shrimp. Enzootic Genetics & Innovation’s core IP is a cell-based technology that taps into the natural sexual plasticity of shrimp to produce all-female populations, without the use of genetic modification, hormones, or chemicals. Enzootic's proprietary all-female freshwater shrimp populations are produced and supplied to farmers in key territories in Asia through Enzootic's independent hatcheries and nurseries. http://enzootic.com Follow us on LinkedIn About NRGene NRGene develops and commercializes cutting-edge AI based genomic tools that are reshaping agriculture and livestock worldwide. Our cloud-based software solutions are designed to analyze big data generated by next generation sequencing technologies in an affordable, scalable and precise manner. By applying our vast proprietary databases and AI-based technologies, we provide leading international agriculture, seed and food companies, with computational tools to optimize and accelerate their breeding programs. For more information visit www.nrgene.com About Ben Gurion University in the Negev Ben-Gurion University of the Negev (BGU) is the fastest growing research university in Israel, fulfilling the vision of David Ben-Gurion, Israel’s legendary first prime minister, who envisaged the future of Israel emerging from the Negev. The University is at the heart of Beer-Sheva's transformation into an innovation district, where leading multinational corporations and start-ups eagerly leverage BGU’s expertise to generate innovative R&D. BGU effects change, locally, regionally, and internationally. With faculties in Engineering Sciences; Health Sciences; Natural Sciences; Humanities and Social Sciences; Business and Management; and Desert Studies. Contact Details Enzootic Genetics & Innovation Amit Hochman - Managing Director +972 52-389-3796 Amit@enzootic.com NRGene Yana Voldman - Marketing Director +972509002844 yana.voldman@nrgene.com BGU Ehud Zion Waldoks - Deputy Spokesperson, International Media +972546775564 ezw@bgu.ac.il Company Website https://www.nrgene.com

April 28, 2021 08:00 AM Eastern Daylight Time

Image

Silicon Valley SaaS Luminaries Open Seed Round for Enterprise AI Startup CIPIO

CIPIO.ai

CIPIO, a B2C Subscription Customer Success company, today announced that Tony Alika Owens and Marge Breya have joined its board of directors and started its seed round. Owens, who previously served as President of Sales Force and Group Vice President of Oracle will be the resident SaaS Growth expert at CIPIO. Having led the launches of multiple Salesforce Portfolio Products, including Einstein, Owens has gathered priceless knowledge on how to roll out and rapidly scale AI-powered SaaS products – a skill that will prove indispensable to CIPIO as it accelerates innovation and growth in the coming months. Breya currently serves as a strategic advisor for 8X8, a leading VoIP solution provider and her leadership in B2B Marketing and Customer Success Strategies for multiple high-growth startups and enterprises will be indispensable in CIPIO’s product roadmap and market expansion. She has extensive B2B GTM and Customer Success expertise spanning over 25 years as a General Manager, Chief Operating Officer, and Chief Marketing Officer – as well as a board veteran – at some of the world’s leading software companies, including SAP, MicroStrategy, Ionic Security, Informatica Corporation, and HP. Breya has also held public company board positions at Jive Software, LSC Communications, and Document Sciences Corporation. “There is no better way for a startup like CIPIO to come out of stealth mode and launch than with a vote of confidence from Tony and Marge,” said Sundeep Sanghavi, Co-Founder and Chairman of CIPIO. “These two powerhouses are proven experts at building, leading, and scaling SaaS companies fast. Their joint decision to invest in CIPIO and kick off our seed round is a strong validation of our team, unique IP, and massive opportunity in one of the fastest growing economies of B2C Subscription.” B2C Subscription Economy is predicted to be @ $478B by 2025 at 68% CAGR, yet its churn rate is double its counterparts in B2B SaaS Economy. CIPIO is uber obsessed with driving growth for B2C Subscription companies through its Domain Infused Data Apps Platform™. “We no longer live in a world where customer lifecycles are linear,” said Owens. “With massive shifts in consumer behavior, B2C Subscription companies need better solutions to minimize churn and boost upsell opportunities. CIPIO’s domain infused Data Apps enables B2C Subscription companies to analyze customer triggers faster, proactively address engagement blindspots and maximize customer impact for repeatable growth and lifetime value.” “CIPIO is determined to bring the power of customer acquisition and retention machine learning to high-churn consumer subscription markets,” said Breya. “Two out of three B2C Subscription companies lack a robust strategy to prevent customer churn. CIPIO’s unique algorithms predict and recommend who, when, what, why, where, and how across mediums and channels enabling B2C Subscription companies to retain customers and drive continuous growth, regardless of transient market dynamics.” About CIPIO: CIPIO is pioneering the Industry's first domain-infused Data Apps Platform™ that humanizes and automates predictions and recommendations to increase Subscriber engagement, retention, and growth for B2C Businesses. CIPIO's early adopters include Crunch Fitness, Industry's Gym, Xponential Fitness, Motor City Church, Pure Barre, Club Pilates, AKT, YogaSix, NCFit, Cyclebar, RowHouse, Stretch Lab, and Stride who have witnessed a significant return on investment in a short time. Contact Details CIPIO Chris Foudy +1 831-238-1905 chris@cipio.ai Company Website https://cipio.ai/

April 27, 2021 01:18 PM Eastern Daylight Time

1 ... 186 187 188 189 190 ... 211